Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
5 participants
INTERVENTIONAL
2022-09-01
2023-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Superior ILM/ERM Flap for the FTMH.
NCT05494242
Double Flap Technique for Macular Hole
NCT05269563
Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study
NCT04859556
Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter
NCT04404296
Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy
NCT01969929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The air infusion will be raised after the valve of one of the trocars will be removed, to allow the air current to dry the clot inside the hole rapidly. Then air gas exchange will be performed to allow the clot to remain away from intraocular fluids for one to two weeks and abolish the possibility of the clot being dissolved.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Utilizing autologous whole blood for the full thickness macular hole
It is an interventional study by performing pars-plana vitrectomy
Pars-plana vitrectomy
Pars-plana vitrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pars-plana vitrectomy
Pars-plana vitrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Omer Othman Abdullah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omer Othman Abdullah
Associate consultant ophthalmologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omer Abdullah, M.Sc.
Role: PRINCIPAL_INVESTIGATOR
Ibinsina Modern Eye and Retina Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Omer Othman Abdullah
Erbil, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMER 111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.